ClinicalTrials.gg
Not yet recruitingNCT07305610PFPSUpdated Dec 26, 2025

INFLUENCE OF SELECTED POSITIONS ON HIP ABDUCTORS STRENGTH AND ACTIVATION IN PATELLOFEMORAL PAIN SYNDROME IN MALES

An observational study in Patellofemoral Pain (PFPS), sponsored by Ahram Canadian University. Not yet recruiting at 1 site in Egypt. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Ahram Canadian University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
44
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

The study aims to explore the effect of body position (side-lying versus standing) on hip abductors muscle strength and activation in individuals with and without PFPS and then to compare these measures between the two groups in each position

Read the detailed description

A cross-sectional comparative study involving 44 subjects (22 subjects with PFPS and 22 healthy controls), aged 18-35 years. The study will measure hip abductor muscle strength (Peak torque, Maximal total work) using the Biodex Isokinetic System 4 PRO and muscle activity (%MVC) of the gluteus medius, gluteus maximus, and tensor fascia lata using Surface EMG (Noraxon Ultium EMG). Measurements will be taken in both standing and side-lying positions.

02

Conditions studied

  • Patellofemoral Pain (PFPS)

Keywords

  • Hip Abductors
  • Muscle Strength
  • Muscle Activity
  • Side-lying
  • Standing
03

In context

Patellofemoral Pain Syndrome

297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.

This study's planned enrollment of 44 is close to the median of 43 across 48 observational studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

Ahram Canadian University is the lead sponsor of 71 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

44 subjects, divided into 22 subjects with PFPS and 22 healthy controls, recruited from the outpatient clinics and staff/students of Ahram Canadian University

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-35 years; Normal ; Subjects in the PFPS group diagnosed with unilateral PFPS by an orthopedist; Healthy individuals without knee pain (for the control group)

Exclusion criteria

Exclusion Criteria:

  • History of lower limb surgery; Any neurological disorders; Musculoskeletal disorders affecting the lower limb; Additional sources of anterior knee pain (tendonitis, Osgood-Schlatter, bursitis, etc.); Any inflammatory diseases
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
44 participants (estimated)
Patient registry
No

Groups and cohorts

  • PFPS Group

    Subjects with unilateral PFPS diagnosed by an orthopedist; age 18-35 years; normal BMI

  • Control Group

    Healthy individuals without knee pain; age 18-35 years; normal BMI

06

What researchers measure

Primary outcomes

  1. Muscle activity (%MVC) of the gluteus medius, gluteus maximus, and tensor fascia lata

    using SEMG

    Time frame: During the assessment procedure (single time point)

  2. Peak torque (Nm) of hip abductors muscles

    using isokinetic

    Time frame: During the assessment procedure (single time point)

Secondary outcomes

  1. Maximal total work (J) during concentric and eccentric contractions

    Using Isokinetic

    Time frame: During the assessment procedure (single time point)

  2. The Arabic Version of the Kujala Score (Anterior Knee Pain Scale)

    A questionnaire

    Time frame: Baseline/Pre-assessment

07

Study locations

1 site
08

References and documents

Publications

  • de Castro MP, Sanchotene CG, Costa GV, Lopes CMS, Hubert M, de Brito Fontana H, Ruschel C. Comparison between side-lying and standing positions for hip abductor strength assessment. J Bodyw Mov Ther. 2022 Apr;30:181-186. doi: 10.1016/j.jbmt.2022.02.011. Epub 2022 Feb 12. PubMed 35500969 ↗

Individual participant data

Plan to share: Undecided — no specific reason

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2025; primary completion for Jan 2026, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2025
First posted
Dec 26, 2025
StartEst.
Dec 15, 2025
Primary completionEst.
Jan 15, 2026
CompletionEst.
Feb 15, 2026
Last update
Dec 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07305610
Lead sponsor
Ahram Canadian University
Responsible party
Mohamed Gouda Mohamed (Dr, Ahram Canadian University) — Principal investigator
First posted
Dec 26, 2025
Start date
Dec 15, 2025 (estimated)
Primary completion
Jan 15, 2026 (estimated)
Completion
Feb 15, 2026 (estimated)
Last update
Dec 26, 2025

Study contacts

MOHAMED GOUDA MOHAMED, bachelor of physical therapy
Contact
mohamed.gouda@acu.edu.eg
+201092948701
mohamed gouda mohamed, bachelor of physical therapy
study chair · Teaching assistant, Department of Physiotherapy, Department of Physical Therapy for Musculoskeletal Disorders and its Surgery, Faculty of Physical Therapy, Ahram Canadian University, Giza, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion